Project Details
Description
Long Term Outcome of the RAD001 B253 Study, Everoliumus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/12 → 10/31/15 |
Funding
- CEDARS-SINAI MEDICAL CENTER
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.